These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 17980929)

  • 1. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW; Ihm SH; Choi MG; Yoo HJ
    Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.
    Visvardis G; Griveas I; Zilidou R; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Pavlitou A; Sakellariou G
    Transplant Proc; 2004; 36(6):1757-9. PubMed ID: 15350470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
    Peczyńska J; Urban M; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella N; George S
    Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
    Rigalleau V; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
    Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cystatin C as estimator of glomerular filtration rate in patients with advanced chronic renal disease].
    Martín MV; Barroso S; Herráez O; de Sande F; Caravaca F
    Nefrologia; 2006; 26(4):433-8. PubMed ID: 17058854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.
    Mueller TF; Raeder J; Oettl K; Zitta S; Klausmann G; Estelberger W; Luyckx VA; Reibnegger G
    Ren Fail; 2008; 30(1):21-9. PubMed ID: 18197539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
    Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
    Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
    Banu N; Hara H; Egusa G; Yamakido M
    Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age.
    Lankisch P; Wessalowski R; Maisonneuve P; Haghgu M; Hermsen D; Kramm CM
    Pediatr Blood Cancer; 2006 Jun; 46(7):767-72. PubMed ID: 16550534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
    Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.
    Maahs DM; Ogden LG; Kretowski A; Snell-Bergeon JK; Kinney GL; Berl T; Rewers M
    Diabetes; 2007 Nov; 56(11):2774-9. PubMed ID: 17660266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
    Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of cystatin C for assessment of renal function after cardiac surgery.
    Heise D; Waeschle RM; Schlobohm J; Wessels J; Quintel M
    Nephron Clin Pract; 2009; 112(2):c107-14. PubMed ID: 19390210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.